Search Orphan Drug Designations and Approvals
-
| Generic Name: | Signal regulatory protein alpha (SIRPalpha)-Exosome |
|---|---|
| Date Designated: | 01/25/2024 |
| Orphan Designation: | Treatment of acute liver failure regardless of etiology |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
SHIFTBIO INC. 76 Hwarang-ro, Unit 102, 103 (1st Floor) Seongbuk-gu Seoul South Korea The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







